RN-2500

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRN-2500
Drug Alias Namerenal cancer Cell therapy (Immunobar)RN-2500
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunobar
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunobar
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A